Fritextsökning
Innehållstyper
-
Han är ny vd på Alligator
Bioteknikföretaget Alligator Bioscience har utsett Søren Bregenholt till ny vd.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Multilabel plate readers with luminescence capability
The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...
-
Definite answer with new cancerous gene
A newly discovered cancer gene is enabling the diagnosis of adenoid cystic caranoima using a genetic test.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Ny glaskeram för tandlagning
Forskare på Ångströmlaboratoriet vid Uppsala universitet har tagit fram glaskeramer lämpliga som tandlagningsmaterial, som är tre gånger starkare än befintliga.
-
Diagnostics to deal with new diseases
Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...
-
A+ anställer medtech-konsult
Helena Fenger-Krog blir medtech-chef på A+ Science.
-
Idogen rekryterar CMO från Oncopeptides
Idogen stärker sin organisation på flera ledande roller inför att bolagets läkemedelskandidat Ido 8 går in i klinisk studie.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Studie: Så länge klarar sig corona på olika ytor
Klarar sig i timmar i luftburna aerosoler och i flera dagar på olika ytor.
-
Därför är det så svårt att hålla sig från snacksen
Okej alla gottegrisar, forskare vid Max Planck institutet och Yale påstår att om vi regelbundet mumsar i oss små mängder livsmedel med högt fett- och sockerinne...
-
Grön kemist vid LTH prisas
Ola Wendt, professor vid Lunds universitet, tilldelas den prestigefyllda Nordblad-Ekstrandmedaljen för sin forskning inom metallorganisk kemi.
-
Hey Klementina Österberg ...
... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.
-
Astrazeneca tappar forskningschef
Briggs Morrison går vidare till nya uppgifter.
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Granskar Mylan-budet
Investeringsbolaget VEB undersöker om budet på svenska Meda bryter mot lagen.
BREAKING